Back ground: A CD4+ T-cell count External Quality Assessment (EQA) program isrnimportant for the evaluation of performance of CD4 count laboratories. rnObjective: The purpose of the present study is to assess the quality of CD4 count laboratoryrnperformance using in-house Proficiency Testing (PT) panels that perform routine CD4 counts in rnAddis Ababa, Ethiopia. rnMethods: Voluntary sampling technique was employed and 20, 23, and 25 laboratories werernparticipated in trials 1, 2, 3 respectively. In-house prepared fresh whole blood samples both with rn68 “normal†and 68 “low†CD4 count materials were sent according to WHO guidelines tornparticipating laboratories. The percentage and absolute counts of CD4+ T-lymphocytes wererndone using their routine procedures. The data were analyzed using Microsoft Excelrn, sigma plotrnversion 12.3, and Graph Pad® Prism version 5 for each trial, for each participant which included;rnthe trimmed mean, standard deviation (SD), the percent coefficient of variation (%CV), thernresidual, and the standard deviation index (SDI) values for both the absolute counts andrnpercentages of CD4+ lymphocytes (%CD4). Feedback was provided to each respectivernparticipant within one month of result submission in each trial. rnResults: Most participating laboratories produced results that were within 2SD of the meanrn(Mean ± 2SD). The average inter-laboratory precision (trimmed %CV) was 10.87% and 5.14% rnfor CD4 absolute counts and CD4% of Lymphocytes respectively. For the normal level CD4rnEQA material, the trimmed mean %CV (between-laboratory precision) was 9.59% and 3.23%rnfor CD4 absolute counts and %CD4 respectively. For the low level CD4 EQA material, therntrimmed mean %CV (between-laboratory precision) was 12.15% and 7.05% for CD4 absoluterncounts and %CD4 respectively. The percentage outlier rate of absolute CD4+ counts and % CD4rnfor all trials were 4.3% and 4.1% respectively. rnConclusion: CD4 EQA program using In-house PT panels was found to help facilities in earlyrnidentifying their gaps with regard to their CD4 count performance. In-house prepared PT panels rnwas helpful in avoiding the challenges encountered during participation in external EQArnproviders like the high cost, transportation problem, feedback delay, CD4 laboratory coverage. rnTM